6955 — Shandong Boan Biotechnology Co Balance Sheet
0.000.00%
- HK$4.60bn
- HK$4.86bn
- CNY618.13m
Annual balance sheet for Shandong Boan Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 3.63 | 614 | 233 | 202 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 30.9 | 126 | 227 | 293 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 92.1 | 940 | 847 | 713 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 491 | 601 | 624 | 660 |
Net Intangible Assets | ||||
Total Assets | 908 | 2,107 | 2,203 | 2,323 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 396 | 260 | 472 | 653 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 426 | 555 | 784 | 1,004 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 482 | 1,552 | 1,418 | 1,320 |
Total Liabilities & Shareholders' Equity | 908 | 2,107 | 2,203 | 2,323 |
Total Common Shares Outstanding |